Alzheimer’s

Direct toxic action of beta-amyloid identified

Scientists have identified early cellular dysfunction in Alzheimer's patients who have already developed clinical symptoms contain large clumps of the protein beta-amyloid, known as plaques.

Common blood pressure pill could slow down Alzheimer’s

While searching for the treatments that slow down the progression of Alzheimer's, scientists discovered that the common blood pressure drug nilvadipine might hold the...

Biggest ever map of human Alzheimer’s brain published

Scientists at the The University of Manchester have created the largest ever dataset of differences between healthy brains and those with Alzheimer’s Disease. Moreover, scientists also...

Scientists may finally know what causes Alzheimer’s

A team of international scientists led by Cortexyme, Inc., a privately held, the clinical-stage pharmaceutical company has recently discovered the role of a common bacterium, Porphyromonas...

Alzheimer’s is not one disease but six different conditions

A new study that involves 19 researchers from several institutions, has suggested a new way to classify patients with Alzheimer's disease. The study suggests that Alzheimer's,...